Ultrasensitive particles offer new way to find cancer

Cancer - Detection

Tiny particles that measure microRNA levels in tissue samples could help diagnose and monitor many diseases.

About 10 years ago, scientists discovered a new type of genetic material called microRNA, which appears to turn genes on or off inside a cell. More recently, they found that these genetic snippets often go haywire in cancer cells, contributing to tumors’ uncontrollable growth.

A team of researchers at MIT has now engineered a way to detect abnormal microRNA levels in the blood of cancer patients, raising the possibility of developing a simple blood test to diagnose or monitor the disease.

Read more: Ultrasensitive particles offer new way to find cancer

   

Sniffing Out Lung Cancer at Early Stages

Cancer - Detection

Changes in body fluid odors indicate presence of lung cancer tumors

New animal research from scientists at the Monell Center and collaborators demonstrates that body fluid odors can be used to identify animals with lung cancer tumors. The findings set the stage for studies to identify potential diagnostic biomarkers in the urine of human lung cancer patients.

Lung cancer is the leading cause of cancer-related deaths worldwide, responsible for 1.3 million deaths annually. Effective techniques for early diagnosis are urgently needed, as the disease often has no early signs or symptoms.

Read more: Sniffing Out Lung Cancer at Early Stages

   

Research Team Designing Holographic Imaging System for Ovarian Cancer

Cancer - Detection

by Rebecca Ruiz-McGill

Two University of Arizona researchers have formed a research team to design, build and evaluate two versions of an ovarian cancer medical imaging and screening instrument that will use holographic components in a new type of optical microscope.

Raymond Kostuk and Jennifer Barton have secured a five-year, $2.4 million grant from the National Institutes of Health to build the instrument that they hope will one day be used to monitor women at high risk for ovarian cancer.  Kostuk is the Kenneth Von Behren Professor of Electrical and Computer Engineering and professor of optical sciences.

Read more: Research Team Designing Holographic Imaging System for Ovarian Cancer

   

New Prostate Cancer Marker

Cancer - Detection

Howard Hughes Medical Institute researchers have identified a new biological marker present in the urine of patients with prostate cancer that indicates whether the cancer is progressing and spreading.

In experiments reported in the February 12, 2009, issue of the journal Nature, the scientists identified 10 metabolites that become more abundant in prostate cells as cancer progresses. Their studies showed that one of these chemicals, sarcosine, helps prostate cancer cells invade surrounding tissue.

Read more: New Prostate Cancer Marker

   

Colon Cancer's Potential for Metastasis Determined Early

Cancer - Detection

Some colon cancers are destined to spread to the liver and other parts of the body, whereas others are successfully treated by surgical removal of the tumor. Now, Howard Hughes Medical Institute investigators have found that the ability of a colon tumor to metastasize arises early in its development.

Those colon cancers that spread carry the ability to metastasize from the time they become cancerous, the researchers found. They don't need to acquire any new genetic mutations to become metastatic. The research also suggests that once a colon carcinoma develops, if it is going to spread outside the colon, it will do so in less than two years.

Read more: Colon Cancer's Potential for Metastasis Determined Early

   

This news service is provided by Good Samaritan Institute, located in Santa Rosa Beach, Florida.

WE PUBLISH PEER_REVIEWED SCIENCE
GSI is a non-profit dedicated to the advancement of medical research by improving communication among scientists.